Kurs Cascadian Therapeutics Inc (USA)

Aktien

04.01.18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
02.01.18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
13.12.17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
07.12.17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer
08.11.17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
WUXI APPTEC CO., LTD.	-4.10%	-8.35%	+38.48%	+66.99%	66.22 Mrd.
ARGENX SE	-0.03%	+3.69%	+10.91%	+74.45%	55.2 Mrd.
LONZA GROUP AG	+1.14%	+4.41%	+12.57%	+92.43%	52.79 Mrd.
IQVIA HOLDINGS INC.	+0.82%	+2.86%	+27.97%	+51.76%	45.53 Mrd.
BEONE MEDICINES AG	-1.43%	+1.91%	+21.58%	+125.93%	43.94 Mrd.
REVOLUTION MEDICINES, INC.	-3.98%	-0.51%	+255.42%	+925.88%	41.64 Mrd.
CELLTRION, INC.	+0.10%	+9.90%	+16.11%	+59.33%	34 Mrd.
WUXI BIOLOGICS (CAYMAN) INC.	-8.38%	-6.95%	+26.35%	-1.93%	25.84 Mrd.
GENMAB A/S	+1.30%	+5.22%	+38.59%	+28.36%	23.51 Mrd.
Durchschnitt	-1.47%	+4.36%	+49.78%	+158.13%	43.19 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	-1.53%	+4.16%	+48.39%	+160.82%